Clinical Updates
Drug approvals, guideline changes, and treatment advances
Experimental Drug DT-109 Reverses Severe Fatty Liver Disease by Repairing Gut Barrier in Animal Studies
An experimental compound called DT-109 reversed severe fatty liver disease in preclinical animal models by restoring intestinal barrier integrity and…
Editor's Top Picks
Engineered Islet Transplant Survives Without Immunosuppression in First-in-Human Trial
A first-in-human trial published in the New England Journal of Medicine demonstrates long-term survival of genetically engineered pancreatic islet cells…
Submit Your Paper →
More form Clinical Updates
FDA Issues Early Alert Over Non-Sterile BD ChloraPrep Applicators in Medline Convenience Kits
The FDA has issued an early alert regarding BD ChloraPrep Applicators in Medline convenience kits…
Only Half of Eligible Adults Complete Bowel Cancer Screening in England
Health officials in England report that fewer than half of eligible 54-year-olds have completed free…
NHS to roll out two rapid diagnostic tests for endometriosis, potentially cutting years from diagnosis
The NHS will introduce two rapid diagnostic tests for endometriosis, aiming to cut the current…
Roche Discontinues Huntington’s Gene-Silencing Program Amid Competitive Pressures
Roche has discontinued its Huntington's disease gene-silencing program, highlighting competitive pressures in neurodegenerative therapeutics. The…
World-First Prenatal Surgery Saves Identical Twins from Life-Threatening Pregnancy Condition
Identical twins Nancy and Margo have become the first patients to survive in-utero surgery for…